Scarica l'app Stockscreener
30.65
3.13%
0.93
Dopo l'orario di chiusura:
30.69
0.04
+0.13%
Precedente Chiudi:
$29.72
Aprire:
$29.65
Volume 24 ore:
626.49K
Relative Volume:
0.77
Capitalizzazione di mercato:
$2.13B
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
+21.24%
1M Prestazione:
-4.64%
6M Prestazione:
+26.29%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$28.61
$31.46
Intervallo di 1 settimana:
$25.27
$31.51
Portata 52W:
$18.84
$39.61
Alamar Biosciences Inc Stock (ALMR) Company Profile
Nome
Alamar Biosciences Inc
Settore
Industria
Telefono
510-626-9888
Indirizzo
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
30.65 | 2.13B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.19 | 117.83B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.67 | 66.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.04 | 51.32B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc Stock (ALMR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-12 | Iniziato | BofA Securities | Neutral |
| 2026-05-12 | Iniziato | JP Morgan | Overweight |
| 2026-05-12 | Iniziato | Leerink Partners | Outperform |
| 2026-05-12 | Iniziato | Stifel | Buy |
| 2026-05-12 | Iniziato | TD Cowen | Buy |
Alamar Biosciences Inc Borsa (ALMR) Ultime notizie
Form 4 Alamar Biosciences: Qiming Corporate GP VI, Ltd. (10% Owner) For: 19 October - Investing.com Canada
Four Qiming holders sold 173,673 Alamar Biosciences (ALMR) shares on October 15–16, 2026. - Stock Titan
Form 144 Alamar Biosciences For: 14 October By Investing.com - Investing.com Nigeria
Form 144 Alamar Biosciences For: 14 October By Investing.com - Investing.com UK
J.P. Morgan is broker for an affiliate’s proposed share sale at Alamar Biosciences (ALMR). - Stock Titan
An affiliate proposes selling 1.56M shares of Alamar Biosciences (Nasdaq: ALMR). - Stock Titan
An affiliate proposes selling 41,945 Alamar Biosciences (ALMR) shares through J.P. Morgan Securities LLC. - Stock Titan
Certain Class B Common Stock of Alamar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 14-OCT-2026. - www.marketscreener.com
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - The Manila Times
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - www.marketscreener.com
Alamar Biosciences Study in The Lancet Neurology Finds Distinct Biomarker Responses to Lecanemab in Early Alzheimer’s Disease - Quiver Quantitative
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment - GlobeNewswire Inc.
Why is Alamar Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Mistras Group, Strategy, Hyperliquid Strategies And Other Big Stocks Moving Higher On Friday - benzinga.com
Ragusa Robert P. Acquires 5,686 Shares and 25,599 Derivative Securities of Alamar Biosciences - Kalkine Media
Alamar Biosciences (ALMR) director has no reported share holdings - Stock Titan
Alamar Biosciences (ALMR) director gets new RSUs and stock option grant - Stock Titan
Alamar Biosciences Slides After Conference Hype Fades - TipRanks
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - manilatimes.net
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire
Alamar Biosciences, Inc. Announces Appointment of Robert Ragusa as Director and Member of Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, Effective September 1, 2026 - marketscreener.com
Alamar Biosciences expands proteomics partnership by 86,000 samples - Investing.com Nigeria
Valion Bio Announces Reverse Stock Split - Yahoo Finance
Alamar Biosciences Stock: Promising But Expensive Proteomics Growth (NASDAQ:ALMR) - Seeking Alpha
Alamar Stock: The Content Flywheel Is More Valuable Than The Instrument (ALMR) - Seeking Alpha
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure - Sahm
Alamar Biosciences (ALMR): Yuling Luo discloses 6.4% beneficial ownership stake - Stock Titan
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - tipranks.com
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - kalkine.ca
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - Kalkine
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - The Globe and Mail
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - theglobeandmail.com
Alamar Biosciences Shares (ALMR) Surge 31% as Consumables Drive Gross Margin Up - TechStock²
Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake - Stock Titan
Alamar Biosciences launches NULISAseq Immune 340 Panel for profiling - scanx.trade
Alamar Biosciences Q2 Results: Revenue Rises 82% To $29.4 Million - scanx.trade
Stifel raises Alamar Biosciences stock price target on earnings beat By Investing.com - Investing.com Canada
Alamar Biosciences Reports Q2 2026 Financial Results in Form 10-Q Filing - Kalkine Media
ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28 - Bitget
Alamar Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside - TradingView
Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary - TradingView
Stifel raises Alamar Biosciences stock price target on earnings beat - Investing.com
Big Sky Industrial Inc. Common Stock Q2 Earnings Call Highlights - Yahoo Finance
Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ... - Yahoo Finance Singapore
Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales - Yahoo Finance
Alamar Biosciences to report Q2 2026 results on August 10, 2026 - scanx.trade
Form 8K Alamar Biosciences For: 10 August By Investing.com - Investing.com Nigeria
Alamar Biosciences Q2 Earnings Call Highlights - MarketBeat
Alamar Biosciences Inc Azioni (ALMR) Dati Finanziari
Non sono disponibili dati finanziari per Alamar Biosciences Inc (ALMR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Alamar Biosciences Inc Azioni (ALMR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. | 10% Owner |
Oct 19 '26 |
Sale |
26.34 |
75,508 |
1,988,881 |
180,808 |
| Qiming Corporate GP VI, Ltd. | 10% Owner |
Oct 16 '26 |
Sale |
27.02 |
136 |
3,675 |
182,128 |
| Qiming Corporate GP VI, Ltd. | 10% Owner |
Oct 15 '26 |
Sale |
27.73 |
173,537 |
4,812,446 |
182,130 |
| Qiming Managing Directors Fund | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.53 |
41,945 |
987,000 |
0 |
| Qiming Venture Partners VIII I | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.52 |
363,729 |
8,555,000 |
0 |
| Qiming Venture Partners VI, L. | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.52 |
1,558,858 |
36,664,000 |
0 |
| Qiming Venture Partners VIII-H | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.52 |
435,468 |
10,242,000 |
0 |
| Naclerio Nicholas | Director |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
| Illumina Innovation Fund II GP | 10% Owner |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
2.13%
3.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):